Anti-FGFR2 Anticorpo (A323310)

Nome
Bemarituzumab Biosimilar - Anti-FGFR2 Antibody - Low endotoxin, Azide free
Descrizione
Recombinant human monoclonal antibody to FGFR2.
Applicazioni
ELISA, FACS, Functional Assay, In Vivo
Reattività
Human, Mouse, Cynomolgus Macaque
Specie ospite
Human
Clonalità
Monoclonal
Isotipo
IgG1
Catene leggere
kappa
Coniugare

Unconjugated

Purificazione
Protein A affinity chromatography.
Concentrazione
Reconstitution dependent.
Peso molecolare
This antibody has a predicted MW of 144 kDa.
Purezza
> 95% (by SDS-PAGE and SEC-HPLC).
Forma del prodotto
Lyophilized
Ricostituzione
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulazione
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Conservazione
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Sinonimi
bacteria-expressed kinase, BBDS, BEK, BEK fibroblast growth factor receptor, BFR1, CD332, CD332 antigen, CEK3, CFD1, Craniofacial dysostosis 1, ECT1, FGF receptor, FGFR 2, FGFR-2, FGFR2_HUMAN, Fibroblast growth factor receptor 2, Hydroxyaryl protein kinase, Jackson Weiss syndrome, JWS, K SAM, K-sam, Keratinocyte growth factor receptor, Keratinocyte growth factor receptor 2, KGFR, KSAM, protein tyrosine kinase, receptor like 14, soluble FGFR4 variant 4, TK14, TK25
Dichiarazione di non responsabilità
Questo prodotto è solo per uso di ricerca. Non è inteso per uso diagnostico o terapeutico.

Prodotti alternativi a Anti-FGFR2 Anticorpo (A323310)

Inizio pagina